What does the FDA actually clear when you write “citrate plasticizer” on a medical-tubing or food-contact PVC spec sheet? The honest answer is: nothing — the agency clears specific grades under specific 21 CFR sections, and the four common citrates carry markedly different clearance scopes. The regulatory landscape is shifting toward per-grade evidence, and a category-level “citrate” line item is the kind of detail compliance reviews now flag.
Compared to traditional phthalates, the citrate family is not a drop-in performance match either: the processing-temperature ceiling is roughly 170-180 °C against phthalate’s 200 °C+, viscosity is lower, and migration profiles differ by an order of magnitude between grades. The actual specification decision sits inside the citrate family, not between citrate and phthalate as categories.
Where Citrates Diverge from Phthalates
Citrates start from citric acid (a tricarboxylic acid hydroxy-ester) instead of phthalic anhydride, so they carry no aromatic ring and hydrolyze cleanly to citric acid plus the alcohol they were esterified with. That backbone is why regulators treat them differently: there is no ortho-phthalate metabolite pathway to worry about, and the hydrolysis products show up in normal human metabolism. REACH Annex XIV restrictions on DEHP, California AB 2300, and the EU MDR phthalate-substantiation requirement together pushed the broader phthalate vs non-phthalate plasticizers shift that put citrates on the table in the first place.
The shift worth tracking starts after the family decision is made. Industry consensus around DEHP replacement has consolidated on three plasticizers — DOTP, TOTM, and ATBC — with DINCH as honorable mention, per Spectrum Plastics’ medical-device PVC review.
Once you commit to citrate, the next decision is which one, and category-level thinking stops being useful. ATBC, TBC, ATEC, and TEC are NF (National Formulary) pharmaceutical-grade designations applied to four different molecules, not interchangeable trade names for the same thing.
Acetyl Tributyl Citrate, Tributyl Citrate, ATEC and TEC Carry Different 21 CFR Clearance
The FDA 21 CFR section list each grade carries shows why “citrate” is too coarse a specification. Compliance requirements now include section-level evidence in food-contact submissions, and the four grades stack very differently:
| Grade | Key 21 CFR Sections | Practical Scope |
|---|---|---|
| ATBC (acetyl tributyl citrate) | 172.515, 175.105, 175.300, 175.320, 181.27 | Broad food-contact stack: flavor adjuvant, adhesives, resinous coatings, polyolefin films, prior-sanctioned plasticizer |
| ATEC (acetyl triethyl citrate) | 175.105, 175.300, 175.320, 178.3910, 181.27 | Adhesives + coatings + lubricants with incidental food contact (178.3910 sits ATEC differently from ATBC) |
| TBC (tributyl citrate) | 175.105 only | Adhesives only; narrow food-contact reach |
| TEC (triethyl citrate) | NF pharmaceutical excipient | Water-solubility limits flexible-PVC food-contact use; migration to dry-food simulant at 15 wt% loading reportedly runs slightly above acceptable limits in industry literature |
The pharmacokinetic differential reinforces the matrix. A 2019 rat study by Yan et al. (PMC6523079) measured ATEC oral bioavailability at 14.8% versus ATBC at 27.4%, with ATEC disappearing from liver microsomes within five minutes due to faster esterase access on the smaller ethyl groups.
“Citrate migration into the patient or the food simulant” is therefore not a single number — it is a per-grade kinetic curve driven by ester chain length, and the regulator-relevant value differs by an order of magnitude between ATEC and ATBC. ISO 10993-12:2021 sets the medical-device extraction baseline (37 °C / 24 h for limited-exposure devices), but the leachable that comes out of that test is grade-dependent.
For specifiers writing a 21 CFR-anchored line item: name the grade, name the section. “Citrate per FDA” without a section ID is the line item that gets returned by compliance review.
Where the Citrate Performance Window Narrows Against Phthalates
Citrates impose a narrower processing and compatibility window than phthalates, and the give-up is per-grade. Three concrete trade-offs determine whether a substitution survives the line.
Tg Suppression by Molecular Weight
DSC measurements in PLA at 30 wt% loading (a comparable plasticizer-efficiency benchmark, though PLA not PVC) showed TEC dropping the polymer Tg from 62.23 °C to 17.49 °C, while ATBC dropped it to 26.91 °C — the lower-molecular-weight ester is more efficient per phr but produces a softer finished part at the same loading. Acetylation also matters: in PVC, ATBC outperforms TBC in tensile strength by 18.7% and ATEC outperforms TEC by 13.9%, so the acetylated grades are the ones that actually deliver phthalate-replacement mechanicals.
Processing-Temperature Ceiling
The citrate family runs at roughly 170-180 °C maximum compared to 200 °C+ for traditional phthalates. Lines accustomed to high-shear DEHP processing have to drop melt temperature, recheck residence time, and often retune cycle. This is the trade you absorb to clear the regulatory bar — not a free swap.
Stress-Cracking on Mixed-Rigidity Assemblies
This is the failure mode most converters miss. Kroushl’s 2016 Teknor Apex test (Medical Design Briefs) put 70 Shore A flexible PVC plasticized with ATBC against rigid polycarbonate and rigid PVC at 23 °C / 50% RH / 3% strain. ATBC induced visible stress cracking in polycarbonate within 0.2 hours and visible stress cracking in adjacent rigid PVC within 14 days; higher-viscosity plasticizers (TOTM, ESBO) showed no cracking after 28 days.
ATBC’s low viscosity (about 32.7 cp) is exactly what makes it efficient for flexible PVC plasticization — and the same property that puts adjacent rigid components at risk on mixed-rigidity assemblies (think flexible IV tubing connectors mating to rigid polycarbonate luer fittings). A blanket “swap DEHP for ATBC” specification without per-interface review will produce field failures.
Citrate Cost Premium Over Phthalates and When the Clearance Earns It
Citrates carry a real cost gap that has to clear procurement review on its own merits. Recent industry estimates put DEHP near USD 1,047/MT FOB Busan, with non-phthalate adipates and citrate esters running 20-40% higher per tonne at commodity scale. Specialty ATBC grades at smaller volumes can land at three to five times DEHP cost.
That premium is defensible only when a specific named clearance pathway is the binding spec constraint — FDA 21 CFR food-contact, EN 71-3 toy-safety, CPSIA 16 CFR 1307, EU MDR phthalate-substantiation. For sensitive PVC duties without one of those clearances binding, terephthalates (DOTP) and cyclohexanoates (DINCH) deliver phthalate-replacement value at a lower premium. Frame the substitution to procurement around the clearance pathway, not the molecule — that is the conversation that survives.
Matching the Citrate Grade — Acetyl Tributyl Citrate, ATEC, TBC, TEC — to the Application
Per-grade selection collapses to four sensitive duties for PVC, with one important blood-storage exception that breaks any blanket “use ATBC” rule.
Medical Tubing (IV Sets, Catheters, Continuous-Fluid-Path Components)
ATBC is the broadly cleared starting point because of its 21 CFR food-contact stack and ISO 10993 biocompatibility track record; this duty can be addressed by ATBC when sterilization method and migration into aqueous media are the binding constraints. Selection on the tubing side also turns on sterilization compatibility (gamma vs ethylene oxide vs autoclave) and the saline vs lipid contact profile — the broader PVC plasticizer for medical-grade tubing selection drills into that side of the decision.
Blood Bags and Extra-Corporeal Lipid-Contact Tubing
ATBC is not the answer here. The field-tested grade is n-butyryl tri-n-hexyl citrate (Citroflex B-6), specifically because of low extractability into lipid media — the plasticizer that survives aqueous saline extraction may not survive blood lipid extraction.
B-6 carries a 20-plus-year service record, European Pharmacopeia listing, and a SCENIHR February 2016 toxicological review. A “citrate plasticizer for blood bag” line item that does not name B-6 versus ATBC is incomplete on the lipid-extractability discriminator alone.
Food-Contact Film and Packaging
ATBC again carries the broadest 21 CFR clearance stack; ATEC fits where the 178.3910 lubricant-with-incidental-food-contact pathway is the regulatory anchor. TBC’s 175.105-only clearance limits it to adhesive applications, and TEC’s water-solubility profile rules it out of fatty / aqueous food-contact use even where the pharma NF clearance would otherwise qualify it.
Pharmaceutical Enteric and Sustained-Release Coatings
All four grades carry NF designation, so regulatory clearance is uniform across the family — but the per-grade decision survives on molecular weight. Aurorium’s pharma-excipient practice: low-MW citrates (TEC, ATEC) at high concentration give high film permeability and fast drug release for immediate-release dosage forms; high-MW citrates (TBC, ATBC) at low concentration give low permeability and slow release for sustained / enteric coatings. Same family, four different release-profile tools.
The Bottom Line
Treat the citrate-versus-phthalate question as a two-step decision, not one. The first step is the family pivot — and once your specific application carries a binding clearance pathway (21 CFR food-contact, EN 71-3, CPSIA, EU MDR), citrates earn the cost premium and DEHP / DINP go off the table.
The second step, where most specifications fall short, is grade-by-application: the broadly cleared acetylated grade for the food-contact stack and standard medical tubing, a different acetylated grade where the 178.3910 lubricant route fits, the n-butyryl tri-n-hexyl variant for blood-storage products, and the molecular-weight-versus-concentration rule for pharma coatings. The deeper change worth tracking is regulatory: compliance reviews are moving past category-level phthalate-versus-non-phthalate framing and now expect grade-level evidence per application duty, which means the per-grade matrix above is the format your spec sheet will be judged against — not a “citrate” line item.